Association of paraoxonase activity and coronary blood flow.
暂无分享,去创建一个
H. Çelik | O. Erel | Ş. Selek | M. Gur | A. Yildiz | R. Demirbağ | R. Yılmaz | M. Polat | R. Demi̇rbağ
[1] H. Gullu,et al. Coronary flow reserve is impaired in patients with slow coronary flow. , 2007, Atherosclerosis.
[2] O. Erel,et al. Paraoxonase and arylesterase activities in coronary artery disease , 2006, European journal of clinical investigation.
[3] M. Nieminen,et al. Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease. , 2006, Journal of the American College of Cardiology.
[4] H. Tanriverdi,et al. Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[5] Chii‐Ming Lee,et al. High-density lipoprotein antagonizes oxidized low-density lipoprotein by suppressing oxygen free-radical formation and preserving nitric oxide bioactivity. , 2005, Atherosclerosis.
[6] K. Sunagawa,et al. Vasospastic angina and microvascular angina are differentially influenced by PON1 A632G polymorphism in the Japanese. , 2005, Circulation journal : official journal of the Japanese Circulation Society.
[7] H. Gullu,et al. Plasma nitric oxide level and its role in slow coronary flow phenomenon. , 2005, International heart journal.
[8] E. Mannarino,et al. Paraoxonase-1 activity modulates endothelial function in patients with peripheral arterial disease. , 2005, Atherosclerosis.
[9] E. Boerwinkle,et al. Q192R polymorphism of the paraoxanase 1 gene and its association with serum lipoprotein variables and carotid artery intima-media thickness in young adults from a biracial community. The Bogalusa Heart Study. , 2004, Atherosclerosis.
[10] J. Danesh,et al. Four paraoxonase gene polymorphisms in 11 212 cases of coronary heart disease and 12 786 controls: meta-analysis of 43 studies , 2004, The Lancet.
[11] O. Erel,et al. A novel automated method to measure total antioxidant response against potent free radical reactions. , 2004, Clinical biochemistry.
[12] J. Steghens,et al. Plasma lipid hydroperoxides measurement by an automated xylenol orange method. , 2004, Analytical biochemistry.
[13] T. Lehtimäki,et al. Smoking-dependent association between paraoxonase 1 M/L55 genotype and coronary atherosclerosis in males: an autopsy study. , 2003, Atherosclerosis.
[14] M. Akkuş,et al. Diffuse intimal thickening of coronary arteries in slow coronary flow. , 2003, Japanese heart journal.
[15] N. Ermis,et al. Vascular endothelial function in patients with slow coronary flow , 2003, Coronary artery disease.
[16] A. Tward,et al. Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice , 2002, Circulation.
[17] P. Durrington,et al. Paraoxonase Status in Coronary Heart Disease: Are Activity and Concentration More Important Than Genotype? , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[18] T. Lehtimäki,et al. Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis. , 2001, Atherosclerosis.
[19] C. Franceschi,et al. The BB-paraoxonase genotype is associated with impaired brachial reactivity after acute hypertriglyceridemia in healthy subjects. , 2001, The Journal of clinical endocrinology and metabolism.
[20] H. Ogawa,et al. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm , 2001, Human Genetics.
[21] P. Amouyel,et al. Paraoxonase polymorphism (Gln192Arg) as a determinant of the response of human coronary arteries to serotonin. , 2000, Circulation.
[22] I. Leviev,et al. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[23] J. Kastelein,et al. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia. , 1999, Atherosclerosis.
[24] A. Abacı,et al. Effect of potential confounding factors on the thrombolysis in myocardial infarction (TIMI) trial frame count and its reproducibility. , 1999, Circulation.
[25] D. Shih,et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis , 1998, Nature.
[26] B. La Du,et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. , 1998, The Journal of clinical investigation.
[27] E. Braunwald,et al. TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.
[28] P. Barter,et al. High density lipoproteins and coronary heart disease. , 1996, Atherosclerosis.
[29] J. Berliner,et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. , 1995, The Journal of clinical investigation.
[30] R. Erbel,et al. Intravascular ultrasound imaging of angiographically normal coronary arteries: a prospective study in vivo. , 1994, British heart journal.
[31] M. Lavallée,et al. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. , 1992, The American journal of physiology.
[32] R. Busse,et al. Endothelium-dependent modulation of vascular tone and platelet function. , 1990, European heart journal.
[33] T. Carew. Role of biologically modified low-density lipoprotein in atherosclerosis. , 1989, The American journal of cardiology.
[34] M. Gotsman,et al. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. , 1986, Circulation.
[35] R. Cannon,et al. Hemodynamic principles in the control of coronary blood flow. , 1985, The American journal of cardiology.
[36] B. La Du,et al. The human serum paraoxonase/arylesterase polymorphism. , 1983, American journal of human genetics.
[37] W. Roberts,et al. Quantitation of coronary arterial narrowing at necropsy in sudden coronary death: analysis of 31 patients and comparison with 25 control subjects. , 1979, The American journal of cardiology.
[38] R Gorlin,et al. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. , 1976, The American journal of cardiology.